期刊文献+

高效液相色谱-荧光法测定丙泊酚的血药浓度 被引量:9

Determination of propofol in plasma by HPLC with fluorescence detection
下载PDF
导出
摘要 目的:建立高效液相色谱-荧光法检测丙泊酚血药浓度的方法。方法:采用饱和硫酸铵溶液作蛋白沉淀剂,以乙腈-水(70:30,含0.1%三氟乙酸)为流动相,流速1.0ml·min-1,荧光检测器检测。结果:丙泊酚血药浓度范围为0.1~10.0mg·L-1,(r=0.999 5);最低检测限为0.02mg·L-1;平均提取回收率为87.03%,RSD为2.54%;平均方法回收率为105.08%,RSD为3.81%;日内差异RSD为4.31%;日间差异RSD为7.54%。结论:本检测方法操作简便、灵敏度高、专一性强、结果可靠,可用于丙泊酚血药浓度监测和药物代谢动力学研究。 Objective: To develop a HPLC method for determination of propofol in human plasma. Methods: Saturated ammonium sulfate was used as deproteinsation solution to prepare sample. 20μl of supernatant was injected. The mobile phase was composed of acetonitrile-water (70:30, containing 0.1% trifluoroacetic acid) as rate of 1.0 ml. min^-1. The fluorescence detector was used. Results: Propofol had a good linear relationship within 0.1-10.0 mg· L^-1 (r = 0.999 5). The limit of detection was 0.02 mg·L^-1 with an injection volume of 20μl. The extracting recovery of propofol was 87.03%, and the method recovery was 105.08%. The RSD of within-day and between-day were 4.31% and 7.54% respectively. Conclusion: The proposed method is simple, sensitive, accurate, reliable, and can be used for blood concentration monitoring and pharmacokinetic studies of propofol.
出处 《天津医科大学学报》 2007年第1期58-60,85,共4页 Journal of Tianjin Medical University
关键词 丙泊酚 血药浓度 HPLC 荧光检测法 Propofol Plasma concentration HPLC Fluorescence detection
  • 相关文献

参考文献8

二级参考文献24

  • 1傅丽红,冉国侠,许伟彬,卡哈尔,逢全,焦士林,曹泽兵.异丙酚临床药物动力学研究[J].中国医院药学杂志,1997,17(2):51-53. 被引量:17
  • 2安刚 薛富善 主编.现代麻醉学技术.第1版[M].北京:科学技术文献出版社,2001.892.
  • 3Guitton J, Desage M. Lepape A, et al. Quantitation of propofol in whole blood by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl, 1995, 669:358-365.
  • 4Tackley RM, Lewis GT, Prys-Roberts C, et al. Computercontrolled infusion of propofol. Br J Anaesth,1989, 62: 46-53.
  • 5Elbast W, Guitton J,Desage M, et al. Comparison between gas chromatography-atomic emission detection and gas chromatography-mass spectrometry for the assay of propofol. J Chromatogr B Biomed Appl, 1996, 686: 97-102.
  • 6Veroli P, O' Kelly B, Bertrand F, et al. Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation. Br J Anaesth, 1992,68: 183-186.
  • 7Galletly DC, Short TG. Total intravenous anaesthesia using propofol infusion-50 consecutive cases[J]. Anaesth Intens Care,1988,16(2):150.
  • 8Jaap VUKY, Swanson RN, Rode Ra, et al. Pharmacodynamics of propofol in female patients[ J ]. Anesthesiology, 1992,77(1):3.
  • 9Murray DM, Thorne GC, Rigby-Jones AE, et al. Electroencephalograph variables, drug concentrations and sedation scores in children emerging from propofol infusion anaesthesia[J]. Paediatr Anaesth,2004,14(2):143 - 151.
  • 10Williams RL. Dosage regimen design: Pharmacodynamic consideration[J]. J Clin Pharmacol, 1992,32(7):597.

共引文献50

同被引文献86

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部